Malaysia faces a mounting public health crisis as cardio-renal-metabolic diseases proliferate across the population, prompting the National Cancer Society Malaysia to demand an urgent, coordinated national screening strategy. The organisation's call reflects deepening concern about how these conditions—encompassing heart disease, chronic kidney complications, and metabolic disorders including diabetes—increasingly appear together in patients, creating compounding health risks that traditional fragmented healthcare approaches fail to address effectively.
The scale of the problem became starkly apparent through a significant community screening initiative conducted last year. The NCSM-Boehringer Ingelheim Saring@Komuniti Project, undertaken with Ministry of Health backing, examined 5,000 individuals from economically disadvantaged areas across the Klang Valley. The results painted a sobering picture of hidden disease burdens that existing healthcare surveillance systems have missed. Nearly all screening participants—97.8 per cent—possessed at least one cardio-renal-metabolic risk factor, demonstrating how pervasive these vulnerabilities have become throughout Malaysian communities.
The screening data revealed alarming prevalence rates across multiple metabolic parameters. Overweight and obesity affected nearly seven in ten participants, with 41.3 per cent classified as obese and a further 28.8 per cent overweight. Blood sugar disorders proved even more widespread, with 34.5 per cent presenting pre-diabetic glucose levels and 35.1 per cent already meeting diabetes diagnostic criteria. These figures suggest that blood sugar regulation problems affect roughly seven in ten screening participants, indicating a massive hidden disease burden that has accumulated undetected in underserved Malaysian communities.
The troubling trend reflects a broader pattern of escalating chronic disease across the country. Chronic kidney disease prevalence more than doubled between 2011 and 2019, climbing from 9.1 per cent to 15.5 per cent of the population. This frightening acceleration has strained dialysis capacity severely; the number of Malaysians requiring dialysis treatment has tripled over the past twenty years, reflecting both the rising disease incidence and the long-term complications developing in patients already living with kidney damage. Without intervention, these trajectories will continue burdening both patients and Malaysia's healthcare infrastructure.
The core problem, according to NCSM analysis, stems from how Malaysia's healthcare system addresses these conditions separately rather than recognising their fundamental interconnectedness. Cardio-renal-metabolic diseases frequently coexist in individual patients, share identical underlying risk factors, and accelerate each other's progression through complex physiological mechanisms. A fragmented approach that screens and manages cardiovascular disease independently from kidney disease or diabetes misses critical opportunities to identify these overlapping vulnerabilities simultaneously, allowing disease to advance unchecked until symptoms emerge.
Current clinical pathways inadvertently perpetuate this fragmentation. Patients completing abnormal screening results often encounter inconsistent follow-up systems, disjointed referral mechanisms, and barriers to continuous care that prevent timely diagnosis and treatment initiation. A person identified as having elevated blood sugar levels during screening may never receive systematic referral to endocrinologists; cardiovascular risk factors may go unaddressed because they appear in different medical record systems. These organisational failures mean that numerous Malaysians with early-stage disease never progress to definitive diagnosis and evidence-based management.
The NCSM policy briefs emerging from this research identify two fundamental priorities requiring national action. First, Malaysia must expand integrated co-screening programmes that simultaneously assess cardiovascular, kidney, and metabolic risk factors across the entire population, rather than conducting separate screening efforts. Second, the healthcare system requires strengthened care continuums ensuring patients identified through screening move seamlessly into proper diagnosis, treatment, and long-term disease management rather than falling through cracks in fragmented referral pathways.
Implementing this vision requires concrete structural changes throughout Malaysia's health system. The policy briefs recommend scaling up integrated CRM screening nationwide, embedding standardised cardio-renal-metabolic risk assessments into routine health checks at primary care clinics and community venues, and fundamentally restructuring referral and follow-up mechanisms to guarantee patients receive coordinated care across specialties. Healthcare professionals would require training to recognise and manage these diseases as an interconnected continuum rather than separate entities.
Dr Murallitharan Munisamy, Managing Director of NCSM, emphasised this paradigm shift: Malaysia possesses an historic opportunity to transition from managing isolated diseases to addressing cardiovascular, kidney, and metabolic health as integrated systems. He stressed that early detection alone proves insufficient; detection must be matched by coordinated follow-up and sustained long-term care if Malaysia hopes to improve health outcomes and prevent the chronic disease burden from overwhelming healthcare capacity. Without this transformation, current trajectories suggest the burden will continue accelerating.
The timing of this advocacy proves critical as Malaysia's healthcare system already strains under existing chronic disease loads. Boehringer Ingelheim Malaysia leadership noted that cardiovascular, kidney, and metabolic conditions interconnect deeply, sharing risk factors and amplifying each other's destructive effects. This recognition that these are not separate epidemics but expressions of common underlying pathophysiology should reshape how Malaysia designs public health strategy and allocates screening resources.
For Malaysian policymakers and health administrators, the NCSM findings present both urgent challenge and opportunity. Implementing integrated national screening represents a substantial organisational and financial undertaking requiring coordination across primary care networks, specialist services, and data systems. Yet the alternative—continuing fragmented approaches while disease prevalence accelerates—ensures deteriorating population health outcomes and unsustainable pressure on hospital and dialysis services. Early detection through integrated screening followed by coordinated care offers the most promising pathway to stemming Malaysia's chronic disease trajectory.
